Klervi Golhen

Basel, BS 4056, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Evaluation of adalimumab tapering regimens in children and adolescents with juvenile idiopathic arthritis in remission: a simulation study.

Evaluation of adalimumab tapering regimens in children and adolescents with juvenile idiopathic arthritis in remission: a simulation study.

Journal: Pediatric rheumatology online journal

Published: July 14, 2025

Influence of Disease Type and Activity on Adalimumab Exposure in Children with Inflammatory Rheumatic Diseases.

Influence of Disease Type and Activity on Adalimumab Exposure in Children with Inflammatory Rheumatic Diseases.

Journal: Journal of clinical pharmacology

Published: December 20, 2024

Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg.

Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg.

Journal: Pharmaceutics

Published: July 26, 2024

Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use.

Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use.

Journal: Journal of clinical pharmacology

Published: January 17, 2024

Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases.

Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases.

Journal: Pediatric rheumatology online journal

Published: August 30, 2023

Melatonin as a Therapy for Preterm Brain Injury: What Is the Evidence?

Melatonin as a Therapy for Preterm Brain Injury: What Is the Evidence?

Journal: Antioxidants (Basel, Switzerland)

Published: July 11, 2023

Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children.

Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children.

Journal: Pharmaceutics

Published: February 24, 2023

Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis.

Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis.

Journal: Frontiers in medicine

Published: May 16, 2022

Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis.

Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis.

Journal: Frontiers in pediatrics

Published: April 05, 2022

Showing 1-9 of 9

Last Updated: 09/26/2026